FDA Approves Glyxambi for Type 2 Diabetes

February 2, 2015 2:36 PM

12 0

The Food and Drug Administration has approved a new medication to improve glycemic control in adults with type 2 diabetes, according to a press release from the drug’s developers.

The drug, Glyxambi, was developed by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. The once-daily tablet is indicated for use alongside diet and exercise to lower blood sugar in type 2 diabetes patients. It is not for patients with type 1 diabetes.

Read more

To category page